Cancer risk in subsolid nodules in the National Lung screening Trial

Radiology

Volumn 293, Issue 2, 2019, Pages 441-448

  Hammer, Mark M ^a   Palazzo, Lauren L ^b   Kong, Chung Yin ^b   Hunsaker, Andetta R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MIDDLE AGED; MULTIPLE PULMONARY NODULES; PATHOLOGY; PRECANCER; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85073577220     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2019190905     Document Type: Article

References (21)

1. Yankelevitz DF, Yip R, Smith JP, et al. CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds. Radiology 2015;277(2):555–564.
2. Henschke CI, Yip R, Smith JP, et al. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds. AJR Am J Roentgenol 2016;207(6):1176–1184.
3. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369(10):910–919.
4. Obayashi K, Shimizu K, Nakazawa S, et al. The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer. J Thorac Dis 2018;10(9):5428–5434.
5. Mortani Barbosa EJ Jr. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated. Acad Radiol 2015;22(8):976–982.
6. Veronesi G, Maisonneuve P, Bellomi M, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012;157(11):776–784.
7. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409.
8. American College of Radiology. Lung-RADS Version 1.1. 2019. https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADSAssessmentCategoriesv1-1. pdf?la=en. Accessed June 21, 2019.
9. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54(2):177–184.
10. UpToDate. Calculator: Solitary pulmonary nodule malignancy risk in adults (Brock University cancer prediction equation). https://www.uptodate.com/contents/ calculator-solitary-pulmonary-nodule-malignancy-risk-in-adults-brock-universitycancer-prediction-equation. Accessed June 22, 2019.
11. White CS, Dharaiya E, Dalal S, Chen R, Haramati LB. Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial. Radiology 2019;291(1):205–211.
12. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377–381.
13. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148(3):839–843.
14. Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013;268(1):265–273.
15. Lim HJ, Ahn S, Lee KS, et al. Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013;144(4):1291–1299.
16. Chung K, Jacobs C, Scholten ET, et al. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. Eur Radiol 2017;27(11):4672–4679.
17. Hammer MM, Palazzo LL, Eckel AL, Barbosa EM Jr, Kong CY. A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules. Radiology 2019;290(2):506–513.
18. Chung K, Jacobs C, Scholten ET, et al. Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? Radiology 2017;284(1):264–271.
19. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15(12):1332–1341.
20. Lee G, Lee HY, Park H, et al. Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art. Eur J Radiol 2017;86:297–307.
21. Cherezov D, Hawkins SH, Goldgof DB, et al. Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial. Cancer Med 2018;7(12):6340–6356.